Press release
Global Pharmacovigilance Market Size, Share, Growth, Analysis, Key Players & Future Outlook, Report | 2025 - 2034
The global pharmacovigilance market value was USD 7.90 billion in 2024, driven by the rising drug consumption across the globe. The market size is anticipated to grow at a CAGR of 11.3% during the forecast period of 2025-2034 to achieve a value of USD 20.71 billion by 2034. This article delves into the dynamics, trends, segmentation, and scope of the global pharmacovigilance market, alongside recent developments, key players, and the impact of COVID-19.Get a Free Sample Report with Table of Contents : https://tinyurl.com/2ao8yee5
Overview of the Global Pharmacovigilance Market
Pharmacovigilance refers to the science and activities involved in detecting, assessing, understanding, and preventing adverse effects or other drug-related problems. With increasing drug consumption globally, pharmacovigilance plays a crucial role in ensuring the safety and efficacy of pharmaceutical products. Regulatory authorities worldwide, such as the FDA, EMA, and WHO, mandate stringent monitoring of drug safety, further driving the growth of this market.
The market's rapid expansion is attributed to factors such as the rising prevalence of chronic diseases, growing pharmaceutical R&D investments, and the emergence of advanced technologies like artificial intelligence (AI) and machine learning (ML) in monitoring drug safety. The increasing need for real-time data analysis and patient safety assurance also contributes to the market's expansion.
Read Full Report with Table of Contents : https://tinyurl.com/2ax492mt
Dynamics of the Global Pharmacovigilance Market
Drivers
Rising Drug Consumption: The growing global population and increasing prevalence of chronic and lifestyle-related diseases have led to heightened drug consumption, necessitating robust pharmacovigilance systems.
Stringent Regulatory Requirements: Regulatory bodies have established stringent guidelines for monitoring adverse drug reactions (ADRs), compelling pharmaceutical companies to adopt advanced pharmacovigilance solutions.
Technological Advancements: The integration of AI, ML, and big data analytics in pharmacovigilance enhances drug safety monitoring and decision-making.
Growing Pharmaceutical R&D Investments: Rising investments in drug development and clinical trials boost the need for comprehensive pharmacovigilance systems to ensure safety.
Restraints
High Costs: Implementing and maintaining pharmacovigilance systems can be costly, especially for small and medium-sized enterprises.
Complexity of Data Integration: Managing and analyzing vast amounts of data from various sources poses challenges.
Opportunities
Emerging Markets: Developing countries offer significant growth opportunities due to increasing healthcare awareness and expanding pharmaceutical industries.
Adoption of Automation: Automated systems can streamline pharmacovigilance processes, reducing costs and errors.
Challenges
Data Privacy Concerns: Ensuring patient confidentiality and data security remains a critical challenge.
Lack of Skilled Workforce: The industry faces a shortage of skilled professionals trained in pharmacovigilance technologies and practices.
External Global Pharmacovigilance Market Trends
Outsourcing Pharmacovigilance Services: Many pharmaceutical companies outsource pharmacovigilance functions to specialized service providers to reduce costs and focus on core operations.
Collaborative Initiatives: Partnerships between pharmaceutical companies, regulatory authorities, and technology providers are fostering innovation and efficiency in drug safety monitoring.
Rising Use of Social Media: Social media platforms are increasingly being used to track and analyze ADRs, offering real-time insights.
Expansion of Biologics and Biosimilars: The growing demand for biologics and biosimilars necessitates rigorous pharmacovigilance to ensure safety.
Global Pharmacovigilance Market Segmentation
By Service Type
Contract Outsourcing: Dominates the market due to cost-efficiency and expertise offered by outsourcing firms.
In-house Services: Preferred by large pharmaceutical companies with substantial resources.
By Clinical Trial Phase
Pre-clinical Phase: Focused on identifying potential ADRs before human testing.
Phase I-IV Clinical Trials: Each phase emphasizes different aspects of safety and efficacy monitoring.
By End-User
Pharmaceutical Companies: Largest segment due to regulatory mandates and high R&D activity.
Hospitals and Clinics: Growing adoption of pharmacovigilance systems for monitoring patient safety.
Regulatory Authorities: Utilize pharmacovigilance data to enforce compliance and safety standards.
By Region
North America: Leading market due to advanced healthcare infrastructure and stringent regulations.
Europe: Significant growth driven by the presence of key pharmaceutical companies and regulatory frameworks.
Asia-Pacific: Rapidly growing region due to expanding pharmaceutical industries and increasing healthcare investments.
Latin America & Middle East/Africa: Emerging markets with untapped potential.
Global Pharmacovigilance Market Growth
Technological Innovations
Advances in technology, such as AI, blockchain, and cloud computing, are revolutionizing pharmacovigilance by enabling real-time data analysis, enhancing transparency, and improving decision-making.
Focus on Patient-Centric Approaches
Pharmaceutical companies are increasingly adopting patient-centric models to improve ADR reporting and enhance patient safety.
Regulatory Support
Governments worldwide are investing in pharmacovigilance systems and promoting awareness to ensure drug safety.
Recent Developments in the Global Pharmacovigilance Market
Launch of AI-Powered Tools: Several companies have introduced AI-powered solutions for efficient ADR detection and management.
Strategic Acquisitions: Mergers and acquisitions among key players have enhanced their capabilities and market presence.
Expansion in Emerging Markets: Leading companies are establishing operations in developing regions to capitalize on growth opportunities.
Integration of Real-World Evidence (RWE): The use of RWE is gaining traction to complement clinical trial data.
Scope of the Global Pharmacovigilance Market
The market encompasses a wide range of activities, including ADR reporting, signal detection, risk management, and regulatory compliance. It spans various therapeutic areas such as oncology, cardiology, neurology, and infectious diseases. The growing focus on personalized medicine and precision therapies further broadens the scope of pharmacovigilance.
Analysis of the Global Pharmacovigilance Market
The market is characterized by high competition, with players focusing on innovation, partnerships, and geographic expansion. The adoption of advanced technologies and increasing regulatory scrutiny are shaping the competitive landscape.
COVID-19 Impact Analysis
The COVID-19 pandemic significantly impacted the pharmacovigilance market. The urgent need for vaccines and therapeutics led to increased ADR reporting and monitoring. Regulatory authorities implemented accelerated approval processes, necessitating robust pharmacovigilance systems to ensure safety.
Key Players in the Global Pharmacovigilance Market
AB Cube (France)
Renowned for its innovative pharmacovigilance software solutions, AB Cube specializes in AI-powered tools for ADR detection and regulatory compliance.
Covance Inc.
A global leader in drug development services, Covance offers comprehensive pharmacovigilance solutions, including data management, risk assessment, and regulatory support.
FAQs
1. What is pharmacovigilance?
Pharmacovigilance involves monitoring, assessing, and preventing adverse effects of pharmaceutical products to ensure their safety and efficacy.
2. What drives the growth of the pharmacovigilance market?
Key drivers include rising drug consumption, stringent regulatory requirements, technological advancements, and growing pharmaceutical R&D investments.
3. Which regions dominate the pharmacovigilance market?
North America leads the market, followed by Europe, due to advanced healthcare infrastructure and regulatory frameworks.
4. How did COVID-19 impact the pharmacovigilance market?
The pandemic accelerated ADR reporting and monitoring activities, highlighting the importance of robust pharmacovigilance systems.
5. What are the key challenges in the pharmacovigilance market?
Challenges include high implementation costs, data integration complexities, and ensuring data privacy.
6. Who are the major players in the market?
Key players include AB Cube (France), Covance Inc., and among others.
7. What is the future outlook for the pharmacovigilance market?
The market is poised for significant growth, driven by technological innovations, emerging markets, and increasing regulatory support.
More Related Content:-
1. North America Balloon Catheters Market : https://tinyurl.com/2bgsghpr
2. North America Stem Cell Assay Market : https://tinyurl.com/268bgmqj
3. Global mHealth Apps Market : https://tinyurl.com/2hfob2h8
Media Contact
Company Name: Claight Corporation
Contact Person: Stephen Grand, Corporate Sales Specialist - U.S.A.
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com
Aus Site: https://www.expertmarketresearch.com.au
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pharmacovigilance Market Size, Share, Growth, Analysis, Key Players & Future Outlook, Report | 2025 - 2034 here
News-ID: 3813389 • Views: …
More Releases from Expert Market Research

Exploring the Global Wine Market Trends, Growth and Insights for 2025-2034
The wine market is one of the oldest and most established beverage sectors worldwide. In 2024, the wine market reached an impressive value of USD 455.56 billion and is poised for significant growth in the coming years. This sector encompasses the production, distribution, and consumption of wine, which includes a wide variety of types such as red, white, sparkling, and fortified wines. The market is influenced by several factors including…

Top Trends in the Soup Market: What's Hot and Delicious in 2025
The soup market is a dynamic and ever-evolving industry, driven by changing consumer preferences and growing demands for convenience foods. Soup, a staple in many households worldwide, is widely regarded for its comforting qualities and versatility. As busy lifestyles continue to push the need for quick, nutritious meal options, the soup market has experienced notable growth.
The market includes a wide range of soup products, including canned soups, instant soups, fresh…

Cell Therapy Market Size to Reach USD 72.84 Billion by 2034, Growing at 18.1% CA …
Cell Therapy Market Overview
The global cell therapy market has emerged as a significant player in modern medicine, driven by increasing investments, groundbreaking research, and the growing prevalence of chronic diseases. Cell therapy involves the transplantation of live cells to replace or repair damaged tissue, offering promising treatment options for conditions such as cancer, cardiovascular diseases, and neurological disorders. With technological advancements and a surge in regulatory approvals, the market has…

Global Guidewires Market Size to Reach USD 1.55 Billion by 2034, Growing at a CA …
Guidewires Market Overview
The global guidewires market is experiencing steady growth, driven by the increasing preference for minimally invasive procedures in various medical specialties. Guidewires are essential components in interventional procedures, facilitating access to target areas in the cardiovascular, neurovascular, and urological fields. Technological advancements, including the development of hydrophilic and hybrid guidewires, are enhancing procedural efficiency and safety. The growing geriatric population, rising prevalence of chronic diseases, and advancements in…
More Releases for Pharmacovigilance
Pharmacovigilance Outsourcing Market 2021 | Detailed Report
Pharmacovigilance Outsourcing Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Pharmacovigilance Outsourcing Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4964765
The report provides a comprehensive analysis of company profiles listed below:
- Clinquest Group B.V
- Cognizant
- LabCorp
- IBM
-…
Global Pharmacovigilance Market & Forecasts
According to a new market research report published by Global Market Estimates, the Global Pharmacovigilance Market is expected to grow at a CAGR of 13.55% during the forecast period. The demand for pharmacovigilance is projected to be high due to the increasing demand for pharmacovigilance services and rising cost-effective initiatives for SMEs companies.
Browse 145 Market Data Tables and 118 Figures spread through 168 Pages and in-depth TOC on "Pharmacovigilance Market…
Pharmacovigilance and Drug Safety Software Market: Pharmacovigilance and Drug Sa …
The global pharmacovigilance and drug safety software market is projected to create new opportunities in the coming years on account of the escalating complexity of drug safety regulations. Among the key contributing factors of the market could be tighter regulatory inspections implemented to control the rise of the incidences of drug-associated adverse events and spiraling concerns pertaining to patient safety.
Pharmaceutical and biotechnology companies are predicted to largely adopt pharmacovigilance software…
Rising Number of Government Pharmacovigilance Centers to Boost Pharmacovigilance …
Pharmacovigilance is a key component of an effective drug regulation system for monitoring and evaluating adverse drug reactions (ADRs). Pharmacovigilance activities are an important part of clinical research and are growing at a significant pace. At present, the global network of pharmacovigilance centers, harmonized by Uppsala Monitoring Centre, are operating on the global level for appropriate functioning of the process of drug safety monitoring across the world. Large volume of…
Pharmacovigilance Market | Forecast up to 2020
Pharmacovigilance is a key component of an effective drug regulation system for monitoring and evaluating adverse drug reactions (ADRs). Pharmacovigilance activities are an important part of clinical research and are growing at a significant pace. At present, the global network of pharmacovigilance centers, harmonized by Uppsala Monitoring Centre, are operating on the global level for appropriate functioning of the process of drug safety monitoring across the world. Large volume of…
Pharmacovigilance Market Research Report Forecast to 2020
Pharmacovigilance is a crucial component of an effective drug regulation system and is used for evaluating and monitoring adverse drug reactions. Pharmacovigilance activities are essential for conducting clinical research. Currently, the global network of pharmacovigilance centers is operating effectively to assure appropriate functioning of drug safety procedures. The large volume of international adverse drug reaction reports collected and stored in a central database assists the national drug regulatory authorities to…